Skip to content
Thursday, June 19, 2025
LibraGen France

LibraGen France

omega-transaminases chiral amines anti-infectious and cancer

  • Corporate overview
  • Distributors
  • Innovative technologies
  • Management
  • Network of partners
  • Research

Research

While focusing the business on the Company’s core skills in biocatalysis and bioprocess technology, LibraGen is investing on high added value proprietary projects in order to ensure mid and long-term creation of value.

Holding key patents on its technology platform and proprietary products, LibraGen is daily combining innovation with industrial know-how.

Share
Facebook Twitter Pinterest Linkedin

Recent Posts

  • Navigating Glycan-Protein Interaction Repositories: Advancing Drug Discovery and Breakthroughs
  • Advancements in Glycosylation Pathways: Defining the Future of Biotechnological Production and Therapeutic Development
  • Glycosylation Patterns and Its Influence on mAbs: Improving Therapeutic Potential Through Glycoengineering
  • Exploiting the efficiency of Glycan-Protein Interactions: A new approach in Vaccine Engineering
  • Glycosylation Patterns and Its Influence on Monoclonal Antibodies: Enhancing Therapeutic Potential Through Glycan Engineering

Categories

  • Blog
  • Uncategorized
All Rights Reserved 2021.
Proudly powered by WordPress | Theme: Refined Blog by Candid Themes.